Oric Pharmaceuticals, Inc.
ORIC· Nasdaq
Released Mar 23, 2021, after the close
10-K filed Mar 23, 2021, 82 days after period end · 0001564590-21-014865
derived · Computed from the longer spans the company filed.
| Metric | Q4 2020dderived from reported figures | Q4 2019dderived from reported figures |
|---|---|---|
| Net Income | -$28.26M | -$8.35M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Oric Pharmaceuticals, Inc. · CIK 1796280 · Engraved from SEC EDGAR
ended Dec 31, 2020 · filed Mar 23, 2021 · 82 d after period end